Converge Bio Raises $25M Series A for Generative AI Drug Discovery

January, 2026

Take a Deep Dive

RSA 2026: From AI Hype to Real Security Infrastructure by Iren Reznikov, Partner

SaaS is dead. Long live AI SaaS. By Leyla Holterud, Partner

Venture Capital Under Chaos: Lessons from Weather Forecasting by Iren Reznikov